| Product Code: ETC7552309 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India RNAI Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India RNAI Therapeutics Market - Industry Life Cycle |
3.4 India RNAI Therapeutics Market - Porter's Five Forces |
3.5 India RNAI Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 India RNAI Therapeutics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 India RNAI Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in India |
4.2.2 Rising investments in research and development of RNAi therapeutics |
4.2.3 Growing awareness about personalized medicine and targeted therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for RNAi therapeutics in India |
4.3.2 High costs associated with development and commercialization of RNAi therapies |
5 India RNAI Therapeutics Market Trends |
6 India RNAI Therapeutics Market, By Types |
6.1 India RNAI Therapeutics Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 India RNAI Therapeutics Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 India RNAI Therapeutics Market Revenues & Volume, By Intradermal Injections, 2021- 2031F |
6.1.4 India RNAI Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F |
6.1.5 India RNAI Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F |
6.1.6 India RNAI Therapeutics Market Revenues & Volume, By Intraperitoneal Injections, 2021- 2031F |
6.1.7 India RNAI Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India RNAI Therapeutics Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 India RNAI Therapeutics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 India RNAI Therapeutics Market Revenues & Volume, By Research and Academic Laboratories, 2021- 2031F |
6.2.4 India RNAI Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 India RNAI Therapeutics Market Import-Export Trade Statistics |
7.1 India RNAI Therapeutics Market Export to Major Countries |
7.2 India RNAI Therapeutics Market Imports from Major Countries |
8 India RNAI Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials initiated for RNAi therapeutics in India |
8.2 Adoption rate of RNAi therapies by healthcare providers and patients |
8.3 Number of partnerships and collaborations in the RNAi therapeutics market in India |
8.4 Investment trends in RNAi therapeutics research and development in India |
9 India RNAI Therapeutics Market - Opportunity Assessment |
9.1 India RNAI Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 India RNAI Therapeutics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 India RNAI Therapeutics Market - Competitive Landscape |
10.1 India RNAI Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here